A Phase I Study of NS-079 in Healthy Participants

by palligoelme@gmail.com | Jun 25, 2026 | Clinical Trials

​ Conditions: Healthy Adult Participants Interventions: Drug: Placebo; Drug: NS-136 tablet; Drug: Paroxetine Sponsors: NeuShen Therapeutics Not yet recruiting Conditions: Healthy Adult Participants Interventions: Drug: Placebo; Drug: NS-136 tablet; Drug: Paroxetine...

Effectiveness of Extracorporeal Shockwave on Planter Fasciitis

by palligoelme@gmail.com | Jun 25, 2026 | Clinical Trials

​ Conditions: Planter Fasciitis; Observational Cohort Study; Effectiveness; Extracoropral Shock Wave Therapy Sponsors: Adly A Adam Completed Conditions: Planter Fasciitis; Observational Cohort Study; Effectiveness; Extracoropral Shock Wave Therapy Sponsors: Adly A...

Colistin Nephrotoxicity and Role of Alpha Lipoic Acid

by palligoelme@gmail.com | Jun 25, 2026 | Clinical Trials

​ Conditions: Nephrotoxicity Interventions: Drug: alpha lipoic acid drug (thioctic acid acid) Sponsors: Helwan University Not yet recruiting Conditions: Nephrotoxicity Interventions: Drug: alpha lipoic acid drug (thioctic acid acid) Sponsors: Helwan University Not yet...

European Multi-Centre Post-Market Registry on Thoracic Endovascular Arch Repair Using Castor™ and Cratos™

by palligoelme@gmail.com | Jun 25, 2026 | Clinical Trials

​ Conditions: Dissection of Thoracic Aorta; Dissection of Thoracic Descending Aorta; Aneurysm of Aorta, Thoracic; Penetrating Aortic Ulcers (PAUs); Intramural Hematoma of the Thoracic Aorta; Ulcer-like Projection (ULP) Interventions: Device: Implantation with Castor™...

Liposomal Iron Versus Ferrous Iron Supplementation for Early Prophylaxis of Iron Deficiency Anemia in Preterm Neonates

by palligoelme@gmail.com | Jun 24, 2026 | Clinical Trials

​ Conditions: Iron Deficiency Anemia in Preterm Neaonates Interventions: Drug: Daily oral ferrous ion; Drug: Daily oral liposomal iron; Drug: Oral liposomal iron every other day Sponsors: Ain Shams University Enrolling by invitation Conditions: Iron Deficiency Anemia...

Combination CurQD and Vedolizumab in Ulcerative Colitis

by palligoelme@gmail.com | Jun 24, 2026 | Clinical Trials

​ Conditions: Ulcerative Colitis Interventions: Drug: CurQD; Drug: Placebo; Drug: Vedolizumab Sponsors: Ryan C Ungaro; United States Department of Defense Not yet recruiting Conditions: Ulcerative Colitis Interventions: Drug: CurQD; Drug: Placebo; Drug: Vedolizumab...